24 May 2019

Three researchers from RIMLS are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO (The Netherlands Organisation for Scientific Research) is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.

Vidi is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20 percent in their field. A Vidi will allow them to conduct research for a period of five years. In this way, NWO stimulates curiosity-driven and innovative research.

We congratulate our researchers with this funding and wish them a lot of success with their great work.


Matthijs Jore, Dept. of Medical Microbiology, theme Infectious diseases and global health

Project: The malaria parasite’s fight against our immune system
Malaria is caused by unicellular parasites that are transmitted by mosquitoes. This research project studies at a molecular level how malaria parasites can evade the human immune system. The obtained insight will be used to develop novel drugs and vaccines against malaria.


Daniele Tauriello, Dept. of Cell Biology, theme Tumors of the digestive tract
Project: Restoring the immune system to prevent cancer from spreading
White blood cells can kill spreading cancer cells but are frequently sidelined by the tumour. The researchers will dissect this process of immune evasion in cultured minitumours to then block it in colon cancer in mice. With this treatment option, they may be able to prevent or cure metastasis.


Johannes Textor, Dept. of Tumor Immunology, theme Cancer development and immune defense
Project: How Intelligent is the Immune System?
Like our brain, our immune system can learn. The researchers will build computer models of the immune system and train these to recognize text and images to understand how the system learns, forgets, and gets confused. This will help to design therapies that use the immune system, such as vaccines.

 

Related news items


Jong KNCV organizes a Pitch competition for PhD candidates

13 August 2020

Are you a PhD candidate and would you like to win 500 euros with a pitch about your research? Young KNCV gives you that chance! During the KNCV Chemistry 2020 Evening on October 8th.

read more

Collective invasion induced by autocrine purinergic loop through connexin-43 hemichannels

13 August 2020

Peter Friedl and Paul Span show in Journal of Cell Biology that breastcancer cells release purines into the extracellular space via connexin-43 hemichannels to control collective invasion.

read more

TP53 allelic state is critical for diagnostic and prognostic precision in blood cancer

12 August 2020

An international study, in which Joop Jansen participated, shows that a double mutaton in TP53 gene deteriotes the prognosis of a rare form of blood cancer. If there is only one mutation or no mutation, then the prognosis is better.

read more

BCG vaccine is safe with no increased risk of COVID-19 symptoms says Mihai Netea

11 August 2020

The BCG vaccine has a general stimulatory effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.

read more

650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

read more

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

read more